Diamant M, Kayser L, Rasmussen A K, Bech K, Feldt-Rassmussen U
Laboratory of Medical Immunology, Rigshospitalet, Copenhagen, Denmark.
Autoimmunity. 1991;11(1):21-6. doi: 10.3109/08916939108994704.
Interleukin-1 is a potent inhibitor of thyroglobulin and cAMP production in human thyroid cells and the inhibitory effect is enhanced by tumor necrosis factor-alpha and interferon-gamma. In the present study secondary cultures of human thyroid cells produced interleukin-6 and the production was significantly increased after exposure of the cells to recombinant interleukin-1 alpha and -1 beta. This increase was dose-dependent and concomitant of the IL-1 induced decrease in cAMP and thyroglobulin production. Both tumor necrosis factor-alpha and -beta also augmented interleukin-6 production, but less potently than interleukin-1. Interferon-gamma did not affect the production of interleukin-6. The rat thyroid cell line FRTL-5 produced interleukin-6 spontaneously, and the production was enhanced after addition of recombinant interleukin-1 beta. A pathogenetic role of interleukin-6 in autoimmune thyroid disease is suggested.
白细胞介素-1是人类甲状腺细胞中甲状腺球蛋白和环磷酸腺苷(cAMP)生成的强效抑制剂,肿瘤坏死因子-α和干扰素-γ可增强这种抑制作用。在本研究中,人类甲状腺细胞的传代培养物产生白细胞介素-6,细胞暴露于重组白细胞介素-1α和-1β后,白细胞介素-6的产生显著增加。这种增加呈剂量依赖性,且与白细胞介素-1诱导的环磷酸腺苷和甲状腺球蛋白生成减少同时出现。肿瘤坏死因子-α和-β也增强白细胞介素-6的产生,但效力低于白细胞介素-1。干扰素-γ不影响白细胞介素-6的产生。大鼠甲状腺细胞系FRTL-5自发产生白细胞介素-6,添加重组白细胞介素-1β后其产生增加。提示白细胞介素-6在自身免疫性甲状腺疾病中具有致病作用。